Syneos Health Partners with Medable to Expand Decentralized Solutions

Article

Syneos Health and Medable have announced a partnership to deliver decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while also aiming to improving patient access and experiences.

Syneos Health will gain access to Medable’s digital platform as well as deliver a decentralized digital solution to Syneos Health customers tailored to the specific attributes and requirements for conducting non-interventional research.

Medable will also now be part of the Syneos Health Dynamic Assembly network, an open ecosystem of data and technology collaborators committed to delivering solutions designed to strategically address the nuances of each customer engagement.

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.